• Green Hygienics Holdings has innovated cannabis cultivation through its use of organic, pesticide-free aeroponic cultivation technology
• The company entered escrow to purchase the 824-Acre Potrero Ranch property near San Diego, California
• This tract of land offers ideal growing conditions for cannabis cultivation, as well as several other related business opportunities

Green Hygienics Holdings Inc. (OTCQB: GRYN), a full-scope, premium cannabis cultivation company targeting the high-end medical and adult-use recreational markets, anticipates a lucrative property acquisition, which could expand its yield capabilities and overall market presence. This 824-acre tract of land, the Potrero Ranch property, is located near San Diego, California, and offers impressive growing potential for the company, which has more than 25 years of experience in agricultural science and innovation.

The Potrero Ranch property boasts expansive grassland pasture surrounded by a curtain of neighboring mountains, providing a natural privacy screen. The other natural elements of the area, including a plentiful water supply, rich soil and altitude, are all conducive to achieving the company’s goal of growing and marketing premium-grade cannabis (http://ibn.fm/p3G8P).

Aside from its natural landscape, the property’s existing infrastructure is also valuable. Multiple outbuildings dot the expansive property, each equipped with “triple phase power, water, and gas services.” These buildings are “ideal for greenhouses or storage,” and the main building features “a large built-in cooler.”

Green Hygienics Holdings Vice President of Business Development Matt Dole noted the lucrative potential of this new property. In a news release, he stated, “Given that there is the potential to harvest 1,200 to 1,500 pounds of hemp per acre, we can produce two crops per year, and the price of hemp is at an average of $50 dollars per pound, this initiative has the potential to produce significant revenues for the Company.” Dole further recognized the enormous potential of this property acquisition to “provide a base of operations for several other equally exciting initiatives.”

Green Hygienics Holdings has already created a name for itself in the burgeoning cannabis industry through its focus on advancing the methodology of cannabis cultivation. The company executes each stage of its aeroponic growing system with precision, giving plants a precise amount of nutrients and water delivered directly to their roots through a fine mist in a controlled environment. This precision allows the company to dramatically reduce waste and crop spoilage, enhancing yield figures and allowing the product to remain organic and fully pest-free. Green Hygienics Holdings utilizes technology that conserves natural resources, using up to 95 percent less water than competitors.

As an established leader in the field, Green Hygienics Holdings anticipates continued growth through its anticipated land acquisition and remains laser focused on maintaining the highest standards of cultivation in order to produce premium-quality cannabis.

For more information, visit the company’s website at www.GreenHygienicsHoldings.com

NOTE TO INVESTORS: The latest news and updates relating to GRYN are available in the company’s newsroom at http://ibn.fm/GRYN

• MCOA wants to extend its CBD-infused hempSMART brand into Asia and Europe using capital raised from the sale of common stock
• March launch of hempSMART in the U.K. kicks off planned entry of the brand into Europe
• hempSMART campaign in U.S. includes participating in high-level events such as the Super Bowl and pre-Academy Awards festivities

Marijuana Company of America Inc. (OTCQB: MCOA) is raising the profile of its hempSMART subsidiary in the United States and is planning an expansion of the brand into Asia and Europe. The company intends to use $10 million in new capital that it plans to raise from the sale of common stock to fund these expansion efforts. MCOA has already filed a form S-1 with the SEC to begin the registration process (http://ibn.fm/GixtI).

MCOA has also begun to unveil the hempSMART brand in the United Kingdom prior to entering the continent of Europe, including scheduling a pre-launch event in London this month. In addition, Marijuana Company of America has established a regional office, a customer service team and a distribution center in London. Field marketing and training have already been completed for hempSMART UK (http://ibn.fm/WTcHc).

In a news release, MCOA CEO Donald Steinberg said, “As legislation continues to evolve and the demand for hemp-derived CBD products grows internationally, we will continue to launch our hempSMART associate marketing model and products to additional countries across the world.”

MCOA conducts product research and development of legal hemp-based consumer products containing CBD under the brand name hempSMART. Focused on general health and well-being, the company also conducts an affiliate marketing program to promote and sell its legal hemp-based consumer products containing CBD. In addition, MCOA is expanding its business into ancillary areas of the legalized cannabis and hemp industry as this segment matures and develops.

To further raise its brand profile in the States, MCOA participated in high-awareness events at Super Bowl LIII and prior to this year’s Academy Awards. During those activities, athletes, celebrities, actors, musicians and other attendees received samples of hempSMART products (http://ibn.fm/BLYYc).

For more information, visit the company’s website at www.MarijuanaCompanyofAmerica.com

NOTE TO INVESTORS: The latest news and updates relating to MCOA are available in the company’s newsroom at http://ibn.fm/MCOA

• Shoppers Drug Mart is now the exclusive direct-to-patient online provider of FlowrRx products
• The agreement between Flowr Corporation and Shoppers Drug Mart is expected to solidify Flowr’s leading position in the Canadian medicinal cannabis market
• Flowr is already a leader in terms of high yields and low production costs – two factors that are proving to be determining for the success of cannabis companies

FlowrRX products by The Flowr Corporation (TSX.V: FLWR) (OTC: FLWPF) are now available for purchase through the Shoppers Drug Mart online medical cannabis platform, as the company announced on March 18, 2019 (http://ibn.fm/rV9dS).

The two companies confirmed a sales agreement at the beginning of 2019. Through the partnership, The Flowr Corporation and Shoppers Drug Mart are simplifying the delivery of medical cannabis products in Canada.

“Flowr’s premium medical cannabis is grown in what we believe is the industry’s most advanced GMP designed cultivation facility. This relationship is testament to our commitment to ultra-high-quality cannabis cultivation and further solidifies Flowr’s role in Canada’s medical cannabis landscape,” co-CEO Vinay Tolia said in a news release.

To order FlowerRX products, patients are required to submit a completed medical document from a health care practitioner to Shoppers Drug Mart. Company advisers will next contact the health care practitioner to verify the document and ensure the immediate completion of the order.

Previously, FlowrRX products were available via the Flowr online store. As per a 2019 agreement, Shoppers Drug Mart is now the exclusive direct-to-patient distributor of FlowrRX products.

Featuring premium quality medicinal cannabis, the FlowrRX range of offerings is the result of Flowr Corporation’s research and development team focusing on innovative cultivars and the creation of unique products. High quality customer service is another key to the delivery of reliable solutions under the FlowrRX brand.

The FlowrRX premium product delivery program incorporates the use of multiple strains ranging from high THC to more balanced options and featuring the company’s BC Delahaze. Delahaze is an award-winning cultivar known for the strong invigorating effect. The cultivar is grown in the Flowr Corporation’s indoor facility to put emphasis on both potency and flavor through consistent control over the cultivation process.

Flowr Corporation is a Health Canada Licensed Producer of cannabis under the Access to Cannabis for Medical Purposes Regulations. The company is emerging as a Canadian leader in the field as a result of its highly advanced, purpose-built cultivation facilities.

Through its innovative cultivation practices, Flowr consistently generates the high crop yields needed for the delivery of premium and ultra-premium cannabis products.

Control over cultivation and innovative practices result in a cost-efficient cultivation process. As the company notes, high yields per square foot are key to ensuring low operating costs and profitability.

For more information, visit the company’s website at www.Flowr.ca

NOTE TO INVESTORS: The latest news and updates relating to FLPWF are available in the company’s newsroom at http://ibn.fm/FLWPF

• Dr. Rebecca Taub, M.D. and Vaughn C. Embro-Pantalony will be joining the BriaCell board of directors
• Both additions have extensive experience in the biopharma industry, bringing expert knowledge in the field of clinical oncology
• Company recently announced a private placement offering that will generate proceeds for the phase IIa combination clinical trial of Bria-IMT with KEYTRUDA in advanced breast cancer

BriaCell Therapeutics Corp. (OTCQB: BCTXF) (TSX.V: BCT), an immuno-oncology-focused biotechnology company developing targeted and safe approaches for the management of cancer, announced several key changes to its board of directors on March 18, 2019, as part of the company’s drive to add shareholder value and further advance its goals (http://ibn.fm/nEvKx).

The company announced the addition of new board members Dr. Rebecca Taub, M.D. and Vaughn C. Embro-Pantalony, and three members of the BriaCell board of directors resigned. As of March 18, the board of directors members that will participate in the April 10 annual shareholders meeting include CEO William V. Williams, director and acting chairman of the board Jamieson Bondarenko and directors Charles Wiseman, Taub and Embro-Pantalony.

Taub served as a chief executive officer and currently serves as chief medical officer and executive vice president for Madrigal Pharmaceuticals Inc. (NASDAQ: MDGL), a clinical stage biopharmaceutical company developing new therapeutic approaches. Previously, she was the senior vice president, R&D, of VIA Pharmaceuticals and the vice president of Hoffman-La Roche. She oversaw clinical development and drug discovery programs.

Taub was a professor of genetics and medicine at the University of Pennsylvania, and she has authored over 120 research articles. She also served as an assistant professor at the Joslin Diabetes Center at Harvard Medical School.

Embro-Pantalony is chairman of the board with Soricimed Biopharma, a private clinical-stage biopharma company developing targeted cancer therapies. He’s also a director at Microbix Biosystems (TSX: MBX), a manufacturer of viral and bacterial antigens and reagents for the global diagnostic industry. Over the years, Embro-Pantalony has held various executive positions focused on finance, strategic planning, business development and IT.

“Both Dr. Taub and Mr. Embro-Pantalony are widely-regarded forces in the biopharma industry, bringing expert prowess in clinical oncology, corporate partnership strategy and board governance,” BriaCell’s Bondarenko said in a news release.

In addition, BriaCell Therapeutics Corp. has also announced a private placement offering to generate proceeds for the company’s phase IIa combination Bria-IMT and KEYTRUDA study (http://ibn.fm/B9vCL). Bria-IMT is BriaCell’s lead drug candidate – an immunotherapy solution for advanced breast cancer patients.

The company’s common shares will be offered at a price of C$0.10 per share for gross proceeds of approximately C$2 million. The offering is scheduled to close on or about March 28, 2019.

Notably, the securities have not been and will not be registered under the U.S. Securities Act of 1933, as amended, or any U.S. state securities laws. They may not be offered in the U.S.

BriaCell Therapeutics Corp. is based in Berkeley, California, and its headquarters are located in Vancouver, British Columbia. The clinical-stage biotechnology company focuses its research and development efforts on targeted immunotherapy for advanced breast cancer patients. Based on the Bria-IMT clinical trials, BriaCell is also developing Bria-OTS, a personalized off-the-shelf immunotherapy solution for advanced breast cancer patients.

For more information, visit the company’s website at www.BriaCell.com

NOTE TO INVESTORS: The latest news and updates relating to BCTXF are available in the company’s newsroom at http://ibn.fm/BCTXF

• Canada’s phased legalization of recreational-use cannabis highlights unfolding opportunities in the cannabis space
• ChineseInvestors.com is continuing to build its presence in the cannabis space while pressing its advantage among Chinese-speaking consumers
• The company is pursuing the possibility of a Nasdaq IPO for its cannabis industry subsidiary later this year, and it’s also contemplating a move to the NYSE or Nasdaq Small Cap Market
• Company recently appointed Patrick Leung as its new CFO

Chinese language investor education service provider ChineseInvestors.com Inc. (OTCQB: CIIX) is flying high as it explores Canada’s unfolding opportunities for the cannabis retail space and the possibility of a Nasdaq IPO for wholly owned cannabis industry subsidiary CBD Biotechnology Co. Ltd. later in the current fiscal year (http://ibn.fm/EqVoL), bolstering its ambition for an uplisting to the New York Stock Exchange or Nasdaq Small Cap Market within the next few years as the company reaches up to $10 million in annual volume. In addition, the company recently appointed Patrick Leung as its new CFO.

“I smell this tremendous, tremendous opportunity for (a) Chinese cannabis company like us… I think of the tremendous opportunities here because there’s not many competitors in the world like us, doing the cannabis business for Chinese people,” ChineseInvestors.com CEO Warren Wang said in a December interview (http://ibn.fm/r1S27).

Wang said that cannabis is one of the twin engines driving CIIX’s flight plan, the other being bitcoin, although bitcoin has been relegated to a backup position at the company’s investors’ request until its market position revives, he indicated. Following up on the Chinese New Year in February, ChineseInvestors.com is hoping to capitalize on cultural expectations for wealth and well-being during the coming year. CBD Biotechnology recently launched its first self-branded rice wine labeled ‘Hemp Wine’ (http://ibn.fm/pZMuE), and CIIX’s second quarter report noted a revenue increase of more than 50 percent year-over-year (http://ibn.fm/9zrSn).

While cannabis use in China is illegal, hemp-based CBD can be legally added to cosmetics, thus opening a potential market of nearly two billion people for the company. In the United States, the company is based in San Gabriel, California, amid the nation’s largest cannabis market.

ChineseInvestors.com is celebrating the advancing tide of cannabis legalization in the United States, including the Georgia House of Representatives vote this month and the governor’s accompanying plan to regulate the manufacture and sale of medical marijuana oil.

The company’s core focus is on offering investment education to its Chinese-speaking audience through real-time market commentary, video reports, podcasts and an online site, utilizing Chinese language character sets (both traditional and simplified). CIIX also provides consulting services to smaller private firms considering their public-listing options, as well as advertising and public business-related support services.

The company is working with Medicine Man Denver to establish a new intellectual property and experience-based corporate entity that will provide licensing and consulting services within the cannabis sector.

For more information, visit the company’s website at www.ChineseInvestors.com

NOTE TO INVESTORS: The latest news and updates relating to CIIX are available in the company’s newsroom at http://ibn.fm/CIIX

• The healthy snack market is growing at a CAGR of 5.2 percent, with an expected reach of $32.88 billion by 2025
• Late-night snacking is a key trend that’s expected to impact the growth of the global food and drink market
• Nightfood’s February rollout of a ‘sleep-friendly’ ice cream that caters to late-night snackers targets a niche; half of Americans already consider ice cream an evening snack

These days it seems that all food-related news is about finding healthy options to satisfy the taste and nutrition demands of a fitness-centric lifestyle. Food occupies a central relationship in celebrations, anniversaries, deaths, weddings, birthdays, family gatherings and bringing coworkers together (http://ibn.fm/Dglen), and it also provides personal comfort for people who are coping with adversity on their own (http://ibn.fm/hrMI9). However, eating habits can sometimes take an unhealthy turn, especially during the late hours of the day (http://ibn.fm/Is8Xr) – a trend that inspired Nightfood Holdings Inc. (OTCQB: NGTF) to produce sleep-friendly snacks for market.

Nightfood’s new ice cream was formulated by sleep and nutrition experts to be sleep-friendly. This means eliminating or minimizing things that are sleep disruptive (excess fat, excess sugar, excess calories) and adding in minerals, amino acids and enzymes that research indicates can support better sleep.

The ice cream fills a product niche with timely importance; analysts at market research firm Mintel have identified nighttime food and beverage consumption as one of six key trends that are “set to impact the global food and drink market” due to the stresses that form a part of the modern lifestyle (http://ibn.fm/Rt0vk).

Analysts at Grand View Research predict that the global healthy snacks market will reach sales of $32.88 billion by 2025, expanding at a CAGR of 5.2 percent during the next six years (http://ibn.fm/q68hD). Marketing that provides consumers with an awareness of options, especially young consumers with some spending power, appear to be driving this growth, according to the report.

Nightfood ice cream began rolling out in February, catering to a population that may want to enjoy a dessert while watching late-night TV or performing other winding-down activities at the end of the day. Big data analysts at IRI Worldwide indicated in the firm’s State of the Snack Food Industry report (http://ibn.fm/sZTVz) that, for many people, ice cream is the go-to snack of choice late in the day. Fast Company magazine cited a recent survey claiming that more than half of Americans consider ice cream an evening snack, with an additional 25 percent classifying it as a late-night indulgence, and Mintel positioned it as the second-most-popular night snack choice (http://ibn.fm/K9MSq).

Nightfood’s ice cream flavors include chocolate, vanilla, chocolate chip cookie dough, decaf coffee, mint chip, ‘bed and breakfast’ and a variation of cookies and cream — all utilizing ingredients designed to be sleep-friendly, such as decaffeinated coffee, a strain of cherries that is naturally high in melatonin and low lactose and high-casein milk protein, along with minerals, enzymes and amino acids to make Nightfood a more appropriate ice cream before bed. The company’s website displays a standard ingredients label for each of the products (http://ibn.fm/VEkOz) and links to a number of media reviews that identify it as comparing well in flavor with premium brand ice creams.

“We looked at everything through the prism of sleep,” founder and CEO Sean Folkson stated in the Fast Company report. “It’s not about, like, dropping an Ambien or some sleep aid into the product; it’s about making ice cream in a way that’s less disruptive.”

Consumer research company Kantar awarded Nightfood with the ‘2019 Product of the Year Award’ in the ice cream category in its annual survey of over 40,000 consumers, and Nightfood is now working toward nationwide distribution in over 10,000 retail outlets by March 31 of next year. The company has already secured distribution in more than 13 states.

Nightfood is also exploring the booming potential of the cannabis food and beverage space through subsidiary MJ Munchies Inc., which aims to market legally compliant cannabidiol (CBD) and marijuana edibles and related products under the trademarked brand name “Half-Baked.”

A news release issued on March 19 noted that Folkson called into SmallCapVoice.com Inc.’s audio interview to discuss the ice cream rollout and a new equity investment from Cincinnati Bengals tight end Tyler Eifert, one of several athletes serving as a brand ambassador for the ice cream (http://ibn.fm/x9ngP).

As Folkson explained in the news release, “The Company is issuing debt to raise cash. Then, it is leveraging that cash in operations to increase the value of the company, and then repaying the same debt with stock at values based on its newly increased valuation. When done properly, this can result in less dilution compared to funding via a more traditional equity structure.”

For more information, visit the company’s website at www.Nightfood.com

NOTE TO INVESTORS: The latest news and updates relating to NGTF are available in the company’s newsroom at http://ibn.fm/NGTF

• Plus Products creates cannabis edibles using extracts
• The company focuses on making safe and delicious cannabis products
• Plus Products is concentrating on growth via acquisitions and product expansion

Plus Products Inc. (CSE: PLUS) (OTCQB: PLPRF) creates safe and flavorful cannabis food products. The company focuses on producing edibles using extracts to ensure compliant, dosable, appetizing products that provide a consistent cannabis experience. A chef from a Michelin-starred restaurant, an Ivy League chemist and food manufacturing experts founded Plus Products. Headquartered in San Mateo, California, the company’s team now includes an impressive roster of professional chefs, chemists, food-manufacturing experts, engineers, machinists, visionaries, creatives and strategists, among others.

PLUS is one of the fastest-growing edible brands in California, with a number of top-selling products (http://ibn.fm/C5eCE). BDS Analytics, an independent cannabis retail sales analytics company, reported that PLUS was the number one edibles brand by retail sales and units sold in Q3 and Q4 2018 (http://ibn.fm/VcsGu). Now, Plus Products is using its knowledge from scaling in California to enter new markets with proven products and brands.

All offerings are produced in the company’s dedicated food-safe cannabis manufacturing facility in Adelanto, California. Dosage is tested twice internally and subsequently tested twice again by an independent lab (http://ibn.fm/4NWWR). In essence, Plus Products maintains an industry-leading focus on making cannabis products that are safe and approachable.

PLUS’ products include Refresh Pink Lemonade-flavored Sativa gummies, Restore Blackberry & Lemon gummies, Uplift Sour Watermelon Sativa gummies, CBD Relief Pineapple & Coconut gummies and Create low-calorie Sour Blueberry gummies. The company also has limited edition products. Its products are innovative combinations of first-rate ingredients. For example, Refresh Pink Lemonade is precisely dosed with 3.5mg of THC (tetrahydrocannabinol) and 1.5mg of CBD (cannabidiol). Restore gummies are made from an infusion of carefully dosed cannabis with kosher ingredients (http://ibn.fm/yDYYj).

Plus Products’ strategy includes dominating the branded product space by taking advantage of data to grow its portfolio organically and via acquisitions (http://ibn.fm/NuWUd). PLUS is also focusing on pairing disciplined, responsive food manufacturing with thoughtful branding teams to create premier products that capture consumers’ attention.

Plus Products is expanding its product line and solidifying its market position. The company is now focusing its attention on adding cannabis-infused baked goods to its already diverse and quality product line. In December 2018, PLUS acquired GOOD CO-OP Inc., a California-based, cannabis-infused baked goods brand in the baked edibles field (http://ibn.fm/wNYFZ). Acquisitions such as this further Plus Products’ vision of growing revenues via new offerings and building brand value.

On March 19, 2019, company co-founder and CEO Jake Heimark presented at the 31st Annual ROTH Conference in Dana Point, California. The ROTH Conference convenes executives from more than 500 public and private companies and approximately 1,000 investors (http://ibn.fm/ZhgCc). In total, an estimated 4,700 attendees gain insight into investment ideas across an array of sectors.

Well-positioned to grab a sizable portion of the branded products space, Plus Products continues to innovate with high-quality ingredients. The company is working to build the leading food-grade cannabis product manufacturing operation in California as it continues to grow sales and market share.

For more information, visit the company’s website at www.PlusProducts.com

NOTE TO INVESTORS: The latest news and updates relating to PLPRF are available in the company’s newsroom at http://ibn.fm/PLPRF

• Company aims to make international trade safer for consumers
• Pacific Software is targeting “zombie meat” (meat from unmonitored sources and possibly exceeding expiration dates) and the health risks that it creates
• Company’s software aims to improve the transparency of supply chains across industries and international borders

Emerging technology corporation Pacific Software Inc. (OTC: PFSF) is strategically positioned for investments, mergers and acquisitions of software technology and platforms. This Toronto-based corporation with a regional office in Hong Kong is poised to deliver a B2B and B2C e-commerce portal. The company is improving product traceability and digitizing the trade process. Finally, by providing various digital solutions, applications and tools that track the origin of products to the sale, Pacific Software is making international trade safer for consumers.

Pacific Software is currently focused on the development and early 2019 launch of BOAPIN.com, an e-commerce trading platform that focuses on cross-border trade expansion, linking Brazilian agriculture suppliers to China. While PFSF is targeting several key industries, including agriculture, fertilizers, chemicals, cosmetics, electronics, equipment, apparel and controlled substance management, its immediate focus lies on beef exports. China has an urgent need for increased transparency in this industry to diminish the “zombie meat” and tainted meat that cross its borders.

China is one of the world’s top meat consumers, and beef is regularly smuggled into the country to meet that demand. However, without proper oversight, this meat is often well past the expiration date, earning it the moniker “zombie meat.” The China Food and Drug Administration reported that, in 2013, frozen chicken claws were smuggled into the country that dated back to 1967. In 2015, authorities seized 100,000 tons of smuggled frozen meat that was reported to be possibly 40 years old (http://ibn.fm/mT0yc). Old and tainted meat clearly presents serious health risk factors. BOAPIN.com will aim to address this problem by providing supply chain transparency and accountability, as well as guaranteeing the safety of products.

PFSF has a strong working relationship with IBM (http://ibn.fm/KPQ4A), which has provided expertise on supply chain implementations. Because of this relationship, Pacific Software has been able to leverage a variety of technologies across multiple verticals and utilize IBM’s Hyperledger Blockchain Backend as a Service (BaaS) infrastructure to target farm-to-table beef exports.

The BOAPIN.com portal is expected to include blockchain solutions, smart contracts with a search interface, digital marketing and fintech applications. This emerging technology has vast application potential, and PFSF is helping to lead the way in creating a more transparent supply chain across industries and international borders.

For more information, visit the company’s website at www.PacificSoftwareInc.com

NOTE TO INVESTORS: The latest news and updates relating to PFSF are available in the company’s newsroom at http://ibn.fm/PFSF

• Private placement closed at $1.8 million, higher than the initial target of $1.75 million
• Proceeds will be used to develop and enhance Wildflower’s manufacturing capability in Washington State; this development will give the company a better chance to address the growing market demand for its products
• Over the years, Wildflower has established a solid distribution network across the U.S., and the company also registered significant growth through its direct-to-consumer online store

Vancouver-based cannabis company Wildflower Brands Inc. (CSE: SUN) (OTCQB: WLDFF) recently announced that it has closed a previously detailed placement of units at a price of C$0.54 per unit. A unit consists of one common share and a half of one share purchase warrant. The placement was closed with aggregate proceeds of up to $1,882,000 – higher than the initially announced target of $1.75 million (http://ibn.fm/JIYMM).

All the proceeds of the financing will be used to build and enhance the company’s manufacturing capability in Washington State so as to meet an increasing demand for Wildflower products, as well as offering general working capital.

Wildflower Brands Inc. is a public cannabis company that develops plant-based wellness and health products. The company markets its full spectrum CBD oil developments to retailers throughout the U.S. and in other legal cannabis markets.

Currently, the U.S. Wildflower distribution network consists of over 200 retailers in Washington State and over 20 retailers in New York City. In addition, the company has partnered up with Retail Worx for the setting up of shop-in-shop retail locations in the heart of NYC and San Francisco. The distribution model also includes over 80 wellness and health care practitioners throughout the U.S.

The Wildflower product development and business growth model is holistic. The company’s operational model encompasses nearly every stage of product creation – research, development, manufacturing, distribution, marketing and retail.

Some of the most prominent brands under the Wildflower umbrella include:

• Wildflower Wellness – provides CBD vaporizers, capsules, tinctures, soaps and topical products
• King Extracts – a California-based company that focuses on cannabis technology and delivery systems
• Exclusive – a high-quality cannabis product dispensary in Los Angeles, California

Wildflower holds 14 cannabis licenses that cover both medicinal and recreational cultivation and manufacturing in California and Los Angeles. Upon activation of these licenses, Wildflower will have an opportunity to drive significant additional revenue with very little risk.

In December 2018, the company started an on-demand cannabis delivery service to adult consumers in the Los Angeles area. To ensure effective deliveries, Wildflower partnered up with Eaze.com. The partnership also facilitates effective inventory management and compliance with all California laws pertaining to legal and licensed cannabis delivery.

A final noteworthy development is the growth of the direct-to-consumer Windflower online store. In 2018, the store registered notable growth in organic demand. Recently, Wildflower announced an increase in online sales of 300 percent and annualized revenues exceeding $1 million for online sales since January 2018. These figures coincide with the platform’s ninth consecutive quarter of growth.

For more information, visit the company’s website at www.WildflowerBrands.co

NOTE TO INVESTORS: The latest news and updates relating to WLDFF are available in the company’s newsroom at http://ibn.fm/WLDFF

• Telecommunications has emerged as a ubiquitous, brand-favored market segment that connects people around the world
• Spectrum Global Solutions serves the telecommunications industry by building and maintaining network services on an end-to-end, one-stop-shopping basis
• The company is preparing to merge with technology innovator WaveTech Global and uplist to the Nasdaq under WaveTech’s brand
• SGSI continues to see contract growth, most recently with more than $1.6 million in new awards announced on March 7

It seems a bit laughable nowadays to recognize that the history of telecommunications began with the use of smoke signals and drums in Africa, the Americas and parts of Asia (http://ibn.fm/EXuQ0). Far separated from that era, modern smartphones and wireless computer video linkages seem to have practically realized the once-fantastic interplanetary technology of the future envisioned by Star Trek’s creators some 50 years ago, and none of the developments that have occurred over the years would be possible without the infrastructure established and maintained by network service providers such as Spectrum Global Solutions Inc. (OTCQB: SGSI).

SGSI is an end-to-end telecommunications insider, providing services and software solutions across the United States and Canada and into the Caribbean.

“We’re able to provide that comprehensive set of services so it’s a one-source engagement with our customers that mitigates the need to hire multiple contractors to perform multiple services — not just across the nation, but they may only need them in specific locations,” SGSI President Keith Hayter told The RedChip Money Report during a January interview (http://ibn.fm/aklRM).

Hayter said that Spectrum Global Solutions has about 200 clients, large and small, providing services “for the installation, construction and maintenance of next-generation infrastructure for telecommunication networks.” The company recently boosted its profile by announcing that it has reached a definitive merger agreement with next-generation technology innovator WaveTech Global Inc. that is expected to see SGSI rebranded under the WaveTech Global name, boosting its aim for Nasdaq exchange uplisting.

The combined companies are expected to have an enterprise value of $130 million. On March 7, SGSI announced that it has received more than $1.6 million in new contract awards to support carrier network upgrades (http://ibn.fm/Djmjh), following on the heels of over $5.8 million in new contract awards to support carrier network upgrades (http://ibn.fm/DCzng), in keeping with its forecast that the company will seek accelerated growth during the year.

While the importance of the telecommunications industry may appear obvious from the emergent ubiquity of cell phones worldwide and Christmas spree spending on electronic devices, the notion is bolstered by analysts at MBLM, who reported in their ‘Brand Intimacy 2019 Study’ (http://ibn.fm/YTAlV) that the technology and telecommunications industry ranked third among consumers for “the emotional science that measures the bonds we form with the brands we use and love.”

Spectrum Global Solutions’ end-to-end capacity to serve clients such as AT&T and Verizon, which are among the top brand intimacy leaders in the industry, with the installation, construction and maintenance of their essential infrastructure demonstrates SGSI’s virtuosity and good name.

As network giants begin to roll out 5G-speed infrastructures during the next few years, the company will find itself in prime position to fulfill the expected growth of client contracts that SGSI has predicted.

“The market opportunity is immense,” Hayter said in a news release. “Over $1.5 trillion is going to be spent on telecommunications. For deployment services, which is where we primarily fit in and get our revenue streams from, from $150 (billion) to 200 billion will be spent over the next couple of years.”

For more information, visit the company’s website at www.SpectrumGlobalSolutions.com

NOTE TO INVESTORS: The latest news and updates relating to SGSI are available in the company’s newsroom at http://ibn.fm/SGSI